Status: Recruiting
Atropine in the Treatment of Myopia Study in Malaysia
This clinical trial is designed to assess the efficacy and safety of Atropine Sulphate 0.025% w/v Eye Drops compared to placebo in a randomized, double-blind, placebo-controlled study for the management of myopia progression in children.
Participants needed: 144
Trial details
Phase: Phase 3Age: 5-10Biological sex: AllType: InterventionalSponsor: IDB VisionCare SDN BHDUpdated: Jan 9, 2026Locations: 2
Eligibility criteria
Male or female children between 5 to 10 years of age. [+12]
History of hypersensitivity or allergy to study drug and/or any of the study med... [+11]